Ciertos inhibidores de proteína cinasa

Se proporcionan ciertos inhibidores de CDK4/6, composiciones farmacéuticas de los mismos y métodos de uso de los mismos. (Traducción automática con Google Translate, sin valor legal) Certain CDK4/6 inhibitors and pharmaceutically acceptable salts thereof are described. In particular, these compounds...

Full description

Saved in:
Bibliographic Details
Main Authors TAN, Rui, CHEN, Zhifang, CHEN, Ling, YANG, Lijun, ZHAO, Xingdong, LIN, Min, SUN, Jing, ZHOU, Zuwen, WANG, Weibo, LI, Tongshuang, WANG, Xianlong, LIU, Yanxin
Format Patent
LanguageSpanish
Published 20.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Se proporcionan ciertos inhibidores de CDK4/6, composiciones farmacéuticas de los mismos y métodos de uso de los mismos. (Traducción automática con Google Translate, sin valor legal) Certain CDK4/6 inhibitors and pharmaceutically acceptable salts thereof are described. In particular, these compounds can inhibit kinase activity of CDK4/6 and may be useful for the treatment of hyper-proliferative diseases like cancer and inflammation. In addition, the pharmaceutical compositions thereof and methods of use thereof are also described.
AbstractList Se proporcionan ciertos inhibidores de CDK4/6, composiciones farmacéuticas de los mismos y métodos de uso de los mismos. (Traducción automática con Google Translate, sin valor legal) Certain CDK4/6 inhibitors and pharmaceutically acceptable salts thereof are described. In particular, these compounds can inhibit kinase activity of CDK4/6 and may be useful for the treatment of hyper-proliferative diseases like cancer and inflammation. In addition, the pharmaceutical compositions thereof and methods of use thereof are also described.
Author CHEN, Zhifang
CHEN, Ling
YANG, Lijun
WANG, Weibo
ZHOU, Zuwen
LI, Tongshuang
LIU, Yanxin
LIN, Min
TAN, Rui
ZHAO, Xingdong
WANG, Xianlong
SUN, Jing
Author_xml – fullname: TAN, Rui
– fullname: CHEN, Zhifang
– fullname: CHEN, Ling
– fullname: YANG, Lijun
– fullname: ZHAO, Xingdong
– fullname: LIN, Min
– fullname: SUN, Jing
– fullname: ZHOU, Zuwen
– fullname: WANG, Weibo
– fullname: LI, Tongshuang
– fullname: WANG, Xianlong
– fullname: LIU, Yanxin
BookMark eNrjYmDJy89L5WRQd85MLSrJL1bIzMvITMpMyS9KLVZISVUoKMovST28Ni9RITkzL7E4kYeBNS0xpziVF0pzMyi6uYY4e-imFuTHpxYXJCan5qWWxLsGG1mamhiaWISEGBsTowYA1-0q2g
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID ES2954148TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_ES2954148TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 13:13:07 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_ES2954148TT33
Notes Application Number: ES20170795490T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231120&DB=EPODOC&CC=ES&NR=2954148T3
ParticipantIDs epo_espacenet_ES2954148TT3
PublicationCentury 2000
PublicationDate 20231120
PublicationDateYYYYMMDD 2023-11-20
PublicationDate_xml – month: 11
  year: 2023
  text: 20231120
  day: 20
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies Fochon Pharmaceuticals, Ltd
RelatedCompanies_xml – name: Fochon Pharmaceuticals, Ltd
Score 3.3486626
Snippet Se proporcionan ciertos inhibidores de CDK4/6, composiciones farmacéuticas de los mismos y métodos de uso de los mismos. (Traducción automática con Google...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Ciertos inhibidores de proteína cinasa
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231120&DB=EPODOC&locale=&CC=ES&NR=2954148T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsbRIM0wxN0vUBd2ZqmtibmShawHMUrpmaQaJKYmmRuZmBqC9w75-Zh6hJl4RphFMDJmwvTDgc0LLwYcjAnNUMjC_l4DL6wLEIJYLeG1lsX5SJlAo394txNZFDdo7BjZWDI0M1FycbF0D_F38ndWcnW2BjSq_IFvQdBaw5R9izMzACmxFm4NWf7mGOYE2pRQg1yhuggxsAUDD8kqEGJhSi4UZOJ1hF68JM3D4Que7gUxo1isWYVB3BlZgJfnFCpl5GaAdc_nAfrJCSqoC-KCFw2vzEhWAWhKLE0UZFN1cQ5w9dIE2xsN9F-8aDHNbiLGxGAMLsNefKsGgYGGUaggMyMTkpBRLE_M04yTjFCMTMwvTFGCHJTnRMk2SQQq3OVL4JKUZuEAhBdpQZ2Qgw8BSUlSaKgusWUuS5MBhAgCXSX19
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLbGQIwbDNAYryKhcqro-3GokNaHCqzdBAXtVqUv0Us70SJ-Fb-CP4ZTtcAFblGiOIklx3aczwa4NPRcSDWVcLRmKidros7pKFKcmvMkJYqoqTzFDvuB6j3JdytlNYCix8K0eULf2-SIKFEJynvT3tfrn0csu_1bWV_HBXZVN25o2mznHaOxIog8a89MZ7mwFxZrWSYaVcGDScNZaPmH0gZsooWt0zT7zvOMglLWvzWKuwtbSyRWNnswyOoxjKy-8NoYtv0u3o3NTvTqfbiyUIE1Vc0U5QtFzFXoJzNpxrSJFj4_SsLgFFKTA7hwndDyOFwx-j5d5Dz2ewsl6RCG6PVnE2B0MROQkSSJU0PWcimWUlFWdSVFhyUhRn4E07_pTP8bPIeRF_rzaH4b3B_DDuUaBdeJ_AkMm9e37BS1bBOftfz5AqGJgG0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Ciertos+inhibidores+de+prote%C3%ADna+cinasa&rft.inventor=TAN%2C+Rui&rft.inventor=CHEN%2C+Zhifang&rft.inventor=CHEN%2C+Ling&rft.inventor=YANG%2C+Lijun&rft.inventor=ZHAO%2C+Xingdong&rft.inventor=LIN%2C+Min&rft.inventor=SUN%2C+Jing&rft.inventor=ZHOU%2C+Zuwen&rft.inventor=WANG%2C+Weibo&rft.inventor=LI%2C+Tongshuang&rft.inventor=WANG%2C+Xianlong&rft.inventor=LIU%2C+Yanxin&rft.date=2023-11-20&rft.externalDBID=T3&rft.externalDocID=ES2954148TT3